‘Senotherapy,’ a treatment that uses small molecule drugs to target “senescent” cells, or those cells that no longer undergo cell division, blunts liver tumor progression in animal models according to new research from a team led by Celeste Simon, PhD, a professor of Cell and Developmental Biology in the Perelman School of Medicine at the University of Pennsylvania and scientific director of the Abramson Family Cancer Research Institute. The study was published in Nature Cell Biology.
- Oahu marine protected areas offer limited protection of coral reef herbivorous fishes
- Picture books can boost physical activity for youth with autism
- Atherosclerosis can accelerate the development of clonal hematopoiesis, study finds
- Deep brain stimulation and exercise restore movement in ataxia
- ‘Explicit instruction’ provides dramatic benefits in learning to read